Update on the pharmacovigilance system for Luxembourg

Update on the pharmacovigilance system for Luxembourg

Luxembourg There has been an update on: New instructions for the preparation and submission of additional risk minimisation material (aRMM) for evaluation and approval in Luxembourg: update contact detail adverse event reportingupdate address to send the printed...

New and improved version of Eudravigilance

EMA On 22 November 2017, a new and improved version of EudraVigilance will be launched by the European Medicines Agency (EMA). Users of this system, including marketing authorization holders and sponsors of clinical trials, should prepare themselves to ensure that...